Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | Cathepsin L-like precursor | 0.0019 | 0.0824 | 0.0649 |
Mycobacterium tuberculosis | Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI) | 0.0021 | 0.1226 | 0.5 |
Loa Loa (eye worm) | exodeoxyribonuclease III family protein | 0.0021 | 0.1226 | 0.1684 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.003 | 0.2818 | 0.3537 |
Plasmodium falciparum | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0021 | 0.1226 | 1 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.004 | 0.4575 | 1 |
Toxoplasma gondii | exonuclease III APE | 0.0021 | 0.1226 | 1 |
Brugia malayi | Cathepsin L-like precursor | 0.0019 | 0.0824 | 0.0649 |
Brugia malayi | Papain family cysteine protease containing protein | 0.0019 | 0.0824 | 0.0649 |
Echinococcus multilocularis | cathepsin L cysteine protease | 0.0019 | 0.0824 | 0.1624 |
Onchocerca volvulus | 0.003 | 0.2818 | 1 | |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.0021 | 0.1226 | 0.5 |
Trypanosoma brucei | cysteine peptidase, Clan CA, family C1, Cathepsin L-like | 0.0071 | 1 | 1 |
Loa Loa (eye worm) | cytoplasmic intermediate filament protein | 0.0016 | 0.0376 | 0.0516 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.0021 | 0.1226 | 0.5 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0055 | 0.7281 | 1 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.004 | 0.4575 | 1 |
Trypanosoma brucei | cysteine peptidase, Clan CA, family C1, Cathepsin L-like | 0.0071 | 1 | 1 |
Schistosoma mansoni | ap endonuclease | 0.0021 | 0.1226 | 0.1501 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0824 | 0.1131 |
Schistosoma mansoni | cathepsin F (C01 family) | 0.0019 | 0.0824 | 0.048 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0055 | 0.7281 | 1 |
Brugia malayi | Cathepsin L-like precursor | 0.0019 | 0.0824 | 0.0649 |
Echinococcus multilocularis | cathepsin l cysteine peptidase | 0.0019 | 0.0824 | 0.1624 |
Schistosoma mansoni | cathepsin F (C01 family) | 0.0019 | 0.0824 | 0.048 |
Schistosoma mansoni | hypothetical protein | 0.0038 | 0.4204 | 0.906 |
Echinococcus multilocularis | cysteine protease | 0.0019 | 0.0824 | 0.1624 |
Echinococcus multilocularis | GPCR, family 2 | 0.0017 | 0.0634 | 0.1201 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0021 | 0.1226 | 1 |
Schistosoma mansoni | intermediate filament proteins | 0.003 | 0.2818 | 0.5541 |
Entamoeba histolytica | hypothetical protein | 0.004 | 0.4575 | 1 |
Trypanosoma brucei | cysteine peptidase, Clan CA, family C1, Cathepsin L-like | 0.0071 | 1 | 1 |
Loa Loa (eye worm) | Papain cysteine protease/cathepsin propeptide inhibitor-containing protein | 0.0019 | 0.0824 | 0.1131 |
Echinococcus multilocularis | cathepsin L cysteine protease | 0.0019 | 0.0824 | 0.1624 |
Echinococcus multilocularis | DNA (apurinic or apyrimidinic site) lyase | 0.0021 | 0.1226 | 0.2522 |
Trypanosoma brucei | cysteine peptidase, Clan CA, family C1, Cathepsin L-like | 0.0071 | 1 | 1 |
Echinococcus granulosus | DNA apurinic or apyrimidinic site lyase | 0.0021 | 0.1226 | 0.2522 |
Loa Loa (eye worm) | intermediate filament protein | 0.003 | 0.2818 | 0.387 |
Plasmodium vivax | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0021 | 0.1226 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0029 | 0.2721 | 0.3738 |
Schistosoma mansoni | ap endonuclease | 0.0021 | 0.1226 | 0.1501 |
Leishmania major | cathepsin L-like protease | 0.0071 | 1 | 1 |
Trypanosoma brucei | cysteine peptidase, Clan CA, family C1, Cathepsin L-like | 0.0071 | 1 | 1 |
Entamoeba histolytica | hypothetical protein | 0.004 | 0.4575 | 1 |
Echinococcus granulosus | lamin dm0 | 0.003 | 0.2818 | 0.6076 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0017 | 0.0634 | 0.1201 |
Loa Loa (eye worm) | hypothetical protein | 0.0017 | 0.0634 | 0.0871 |
Trypanosoma brucei | cysteine peptidase, Clan CA, family C1, Cathepsin L-like | 0.0071 | 1 | 1 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0017 | 0.0634 | 0.1201 |
Entamoeba histolytica | hypothetical protein | 0.004 | 0.4575 | 1 |
Loa Loa (eye worm) | papain family cysteine protease containing protein | 0.0019 | 0.0824 | 0.1131 |
Trypanosoma brucei | cysteine peptidase, Clan CA, family C1, Cathepsin L-like | 0.0071 | 1 | 1 |
Trypanosoma cruzi | cysteine peptidase, putative | 0.0071 | 1 | 1 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0017 | 0.0634 | 0.0375 |
Loa Loa (eye worm) | hypothetical protein | 0.0038 | 0.4204 | 0.5775 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0055 | 0.7281 | 1 |
Echinococcus granulosus | cathepsin L cysteine proteinase | 0.0019 | 0.0824 | 0.1624 |
Brugia malayi | hypothetical protein | 0.004 | 0.4575 | 0.6081 |
Echinococcus granulosus | intermediate filament protein | 0.003 | 0.2818 | 0.6076 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0017 | 0.0634 | 0.0375 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0021 | 0.1226 | 1 |
Onchocerca volvulus | 0.003 | 0.2818 | 1 | |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0017 | 0.0634 | 0.1201 |
Trypanosoma brucei | cysteine peptidase, Clan CA, family C1, Cathepsin L-like | 0.0071 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.004 | 0.4575 | 1 |
Brugia malayi | Cathepsin L-like precursor | 0.0019 | 0.0824 | 0.0649 |
Echinococcus multilocularis | lamin | 0.003 | 0.2818 | 0.6076 |
Brugia malayi | exodeoxyribonuclease III family protein | 0.0021 | 0.1226 | 0.1232 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.003 | 0.2818 | 0.387 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease, putative | 0.0021 | 0.1226 | 0.0438 |
Trypanosoma cruzi | cysteine peptidase, clan CA, family C1, cathepsin L-like, putative | 0.0064 | 0.892 | 0.8824 |
Trypanosoma cruzi | cysteine peptidase, putative | 0.0071 | 1 | 1 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0038 | 0.4204 | 0.5545 |
Echinococcus granulosus | lamin | 0.003 | 0.2818 | 0.6076 |
Brugia malayi | Cathepsin L-like precursor | 0.0019 | 0.0824 | 0.0649 |
Echinococcus granulosus | GPCR family 2 | 0.0017 | 0.0634 | 0.1201 |
Giardia lamblia | Endonuclease/Exonuclease/phosphatase | 0.0021 | 0.1226 | 0.5 |
Brugia malayi | intermediate filament protein | 0.003 | 0.2818 | 0.3537 |
Echinococcus multilocularis | cathepsin l cysteine peptidase | 0.0019 | 0.0824 | 0.1624 |
Loa Loa (eye worm) | ctsf protein | 0.0019 | 0.0824 | 0.1131 |
Trypanosoma brucei | cysteine peptidase, Clan CA, family C1, Cathepsin L-like | 0.0071 | 1 | 1 |
Trypanosoma cruzi | major cysteine proteinase, putative | 0.0055 | 0.7337 | 0.7098 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease | 0.0021 | 0.1226 | 0.0438 |
Trypanosoma brucei | cysteine peptidase, Clan CA, family C1, Cathepsin L-like | 0.0071 | 1 | 1 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.004 | 0.4575 | 1 |
Echinococcus multilocularis | musashi | 0.003 | 0.2818 | 0.6076 |
Echinococcus multilocularis | cysteine protease | 0.0019 | 0.0824 | 0.1624 |
Leishmania major | apurinic/apyrimidinic endonuclease-redox protein | 0.0021 | 0.1226 | 0.0438 |
Mycobacterium ulcerans | exodeoxyribonuclease III protein XthA | 0.0021 | 0.1226 | 0.5 |
Echinococcus granulosus | cathepsin l1 | 0.0019 | 0.0824 | 0.1624 |
Loa Loa (eye worm) | hypothetical protein | 0.003 | 0.2818 | 0.387 |
Echinococcus granulosus | cathepsin l cysteine peptidase | 0.0019 | 0.0824 | 0.1624 |
Loa Loa (eye worm) | hypothetical protein | 0.0055 | 0.7281 | 1 |
Loa Loa (eye worm) | cysteine protease | 0.0019 | 0.0824 | 0.1131 |
Trypanosoma brucei | cysteine peptidase, Clan CA, family C1, Cathepsin L-like | 0.0071 | 1 | 1 |
Entamoeba histolytica | exodeoxyribonuclease III, putative | 0.0021 | 0.1226 | 0.1073 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0017 | 0.0634 | 0.0871 |
Loa Loa (eye worm) | fibroinase | 0.0019 | 0.0824 | 0.1131 |
Schistosoma mansoni | lamin | 0.003 | 0.2818 | 0.5541 |
Trypanosoma cruzi | cysteine peptidase, putative | 0.0071 | 1 | 1 |
Echinococcus multilocularis | lamin dm0 | 0.003 | 0.2818 | 0.6076 |
Brugia malayi | Cathepsin L-like precursor | 0.0019 | 0.0824 | 0.0649 |
Leishmania major | cathepsin L-like protease | 0.0071 | 1 | 1 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0017 | 0.0634 | 0.1201 |
Loa Loa (eye worm) | hypothetical protein | 0.0014 | 0.0096 | 0.0132 |
Entamoeba histolytica | hypothetical protein | 0.004 | 0.4575 | 1 |
Trypanosoma cruzi | cruzipain precursor, putative | 0.0071 | 1 | 1 |
Schistosoma mansoni | lamin | 0.003 | 0.2818 | 0.5541 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
GI50 (functional) | = 0.15 uM | Cytotoxicity against human KB cells after 48 hrs by SRB assay | ChEMBL. | 20444601 |
GI50 (functional) | = 0.16 uM | Cytotoxicity against human MCF7 cells after 48 hrs by SRB assay | ChEMBL. | 20444601 |
GI50 (functional) | = 0.17 uM | Cytotoxicity against human PC3 cells after 48 hrs by SRB assay | ChEMBL. | 20444601 |
GI50 (functional) | = 0.17 uM | Cytotoxicity against human A2780 cells after 48 hrs by SRB assay | ChEMBL. | 20444601 |
GI50 (functional) | = 1.8 uM | Cytotoxicity against human SiHa cells after 48 hrs by SRB assay | ChEMBL. | 20444601 |
GI50 (functional) | = 2 uM | Cytotoxicity against human A549 cells after 48 hrs by SRB assay | ChEMBL. | 20444601 |
GI50 (functional) | = 2 uM | Cytotoxicity against human ZR-75-1 cells after 48 hrs by SRB assay | ChEMBL. | 20444601 |
GI50 (functional) | = 2.3 uM | Cytotoxicity against human HOP62 cells after 48 hrs by SRB assay | ChEMBL. | 20444601 |
GI50 (functional) | = 25 uM | Cytotoxicity against human COLO205 cells after 48 hrs by SRB assay | ChEMBL. | 20444601 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.